Ovarian Cancer | Tumor

CURE’s ovarian cancer page is a go-to resource for oncology news and updates in the world of ovarian cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in ovarian cancer.

Finding Success In Immunotherapy Trials

January 20th 2020

One cancer survivor details how her immunotherapy changed her cancer journey for the better, and how ongoing trials of immunotherapy are looking to change the cancer landscape for the better.

Appreciating The Gift of Time is the Best New Year Resolution For This Cancer Patient

January 15th 2020

Patients with cancer are acutely aware of how time is finite, and that's ok. They can appreciate the fit of time all the better.

Findings Show No Statistically Significant Link Between Talcum Powder And Ovarian Cancer

January 9th 2020

In a new study, researchers set out to prove whether or not there was a statistically significant risk of ovarian cancer from the use of talc-based powder.

When I Needed to Talk

January 8th 2020

One cancer survivor discusses the need to talk to others during and after her treatment, and the healing ability of listening as well.

The Space In Between

January 8th 2020

One woman reflects on the fact that no one is immortal.

What Happens After Genetic Testing? A Podcast Illuminates a Challenging Road

January 8th 2020

Launched in April 2018, the podcast hosted by Eleanor Griffith of Grey Genetics tells the stories of people living with genetic mutations that predispose them to cancer or other diseases.

The Falling, Wandering and Crashing Business of Cancer Treatment Side Effects

December 26th 2019

If you’ve experienced neuropathy, you know what it entails.

A Guide for Caregivers

December 19th 2019

One patient provides potential caregivers “a guide to help you help me”.

'Speaking Out' on Legal Protection in Cancer

December 19th 2019

In this week’s episode of the “CURE Talks Cancer” podcast, we spoke with Lisa Schlager, from FORCE, about the types of legal protections in place for those with a genetic risk for cancer.

How Genetic Testing Saved One Woman's Life

December 6th 2019

Two-time cancer survivor Anne Weber feels fortunate to have learned of her BRCA2 gene mutation, as it led to an early diagnosis of aggressive breast cancer.

CURE's Clinical Trial Corner: November 2019

November 30th 2019

Here is a list of the recent trial initiations that occurred within the cancer space in November.

Friday Frontline: Cancer Updates, Research and Education on November 29, 2019

November 29th 2019

From the first patient death under the Right to Try law to a 9-year-old ovarian cancer survivor meeting her hero Jim Cantore, here’s what is making headlines in the cancer space this week.

Dealing With a Second Relapse

November 26th 2019

“When learning about a second relapse, the only thing I could think was, ‘Oh no. Not again. This cannot be happening.”

When Cancer Comes Back

November 18th 2019

You never expect to get a diagnosis of cancer, but what about when it comes back?

New Guidelines Call for Gene Screening for Cancer Survivors

November 8th 2019

Revised federal guidelines recommend that more women, especially cancer survivors, be considered for genetic screening for hereditary breast and ovarian cancer.

Counting the Days of Chemotherapy

November 6th 2019

I was never any good at math, but I can count. So I learned to live by this bit of information by counting the days that passed after my treatments for ovarian cancer.

What You Need to Know About the FDA's Approval of Zejula

November 1st 2019

The Food and Drug Administration’s recent approval of Zejula for certain patients with advanced ovarian, fallopian tube or primary peritoneal cancer was the first PARP inhibitor approved for the treatment, not the maintenance, of these women.

Day One is Always Memorable in the Saga of Chemotherapy

October 30th 2019

Looking back on Day One in the chemotherapy journey.

FDA Approves Zejula for Advanced Ovarian Cancer Subset

October 23rd 2019

The Food and Drug Administration has approved Zejula for patients with advanced ovarian, fallopian tube, or primary peritoneal cancer that have been treated with three or more prior chemotherapy regimens and whose cancer is associated with homologous recombination deficiency-positive status.

Testing for Honesty

October 23rd 2019

Before getting genetic testing for hereditary ovarian, breast or other cancers, make sure the company providing it is both reputable and qualified.

The Diagnosis From Hell

October 22nd 2019

"They say once you hear the word cancer, you retain maybe 40 percent of the information that follows, but the words 'ovarian cancer' got through alright."

Ovarian Cancer: Considering the Experience of Caregivers

October 18th 2019

A Network of Support for Patients With Ovarian Cancer

October 18th 2019

Addressing Mental and Emotional Health in Ovarian Cancer

October 18th 2019

Compartmentalizing Stigma and Support in Ovarian Cancer

October 18th 2019

When to Consider Maintenance Therapy for Ovarian Cancer

October 18th 2019

Ovarian Cancer: What is the Benefit of Maintenance Therapy?

October 18th 2019

Recurrent Disease: Learning to Live With Cancer

October 18th 2019

Reacting to a Diagnosis of Recurrent Ovarian Cancer

October 18th 2019

Adjusting to Life During Treatment of Ovarian Cancer

October 18th 2019